Interim analysis
Clinical trials are unique in that enrollment of patients is a continual process staggered in time. This means that if a treatment is particularly benefitial or harmful compared to the concurrent placebo group, the investigators are ethically obliged to assess that difference and to terminate the study earlier than planned.
Statistical methods of interim analysis
Regulatory issues
Practical issues
 | This statistics-related article is a stub. You can help Wikipedia by expanding it. |